TET2, which was the most significantly downregulated gene, is universally considered as a tumor-suppressor gene and could modulate Th1 and Th17 cell differentiation and T-cell cytokine production in vivo in autoimmune diseases [18]. This evidence concerns the gene TET2 and neoplasm.